In this podcast Dr Anna Volkmer, convenes a panel of world-renowned experts from University College London. They discuss the discovery of amyloid and its role in Alzheimer’s Disease and take an in-depth look into the latest developments surrounding Lecanemab and Donanemab, monoclonal antibodies (mAbs) as a treatment and Gene Silencing. 

This week’s guests are Professor Sir John Hardy, Geneticist and trailblazer in neurodegenerative disease research, Professor Nick Fox, Neurologist, and eminent figure in the fields of neuroimaging and clinical neuroscience, and Dr Cath Mummery, Neurologist and leading light in cognitive disorders and clinical trials.
--

Listeners can expect:
1.	🧠 - Discussion on new dementia drugs Lecanemab and Donanemab.
2.	🔬 - Insights on the science behind these treatments, the story behind the discovery of amyloid and familial Alzheimer’s - Carol Jennings Story.
3.	❌🤔 - Clarification of misconceptions about dementia therapies.
4.	🩺💊 - Information on the impact of these drugs on patients and clinical practice.
5.	🌟🔜 - A look at the future of dementia research, including gene-silencing therapies.
--

NIA statement on report of lecanemab reducing cognitive decline in Alzheimer’s clinical trial:
https://www.nia.nih.gov/news/nia-statement-report-lecanemab-reducing-cognitive-decline-alzheimers-clinical-trial

NIA statement on donanemab results: More Alzheimer’s research progress:
https://www.nia.nih.gov/news/nia-statement-donanemab-results-more-alzheimers-research-progress

Alzheimer's Society Information on Donanemab:
https://www.alzheimers.org.uk/blog/what-is-donanemab-alzheimers-drug

Alzheimer's Society Information on Lebanemab:
https://www.alzheimers.org.uk/blog/lecanemab-new-drug-early-stage-alzheimers-disease

Alzheimer's Association Info on Research & Risks
https://bit.ly/3QxH3Ei

--

Full biographies on all our guests and a transcript can be found on our website http://www.dementiaresearcher.nihr.ac.uk
--

Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode – and if you prefer to watch rather than listen, you’ll find a video version of this podcast with full captions on our YouTube Channel.
https://youtu.be/Kl8rzDSIwxM 
--

This podcast is brought to you by University College London / UCLH NIHR Biomedical Research Centre in association with Alzheimer’s Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia who we thank for their ongoing support.

A Closer Look At Lecanemab Donanemab And Amyloid

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about research that suggests a potential link between dietary choices and the development or prevention of Alzheimer disease and how dietitians can integrate this knowledge into their practice to support cognitive health in their clients. This is episode one of a four-part podcast series on Alzheimer disease.

The Impact of Dietary Choices on Alzheimer Disease Prevention

In this podcast episode, Lisa Jones interviews Amylee Amos, PhD, RDN, IFMCP, about how dietitians can effectively translate the latest research on diet and Alzheimer disease into practical dietary recommendations for individuals at risk or diagnosed with Alzheimer disease, including the nuances of individualized nutrition needs. This is episode two of a four-part podcast series on Alzheimer disease.

Practical Dietary Recommendations for Patients at Risk, Diagnosed With Alzheimer Disease

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the key arguments and controversies surrounding specific diets in relation to Alzheimer disease prevention and management, and how dietitians can navigate controversies to provide the best guidance for their clients. This is episode three of a four-part podcast series on Alzheimer disease.

Controversies in the Impact of Diet on Alzheimer Disease Prevention, Management

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the practical and actionable nutrition strategies that dietitians can recommend to individuals managing Alzheimer disease to help improve cognitive function, enhance overall quality of life, and provide meaningful support in their daily lives. This is episode four of a four-part podcast series on Alzheimer disease.

Nutrition Strategies for Improved Cognitive Function in Patients With Alzheimer Disease

In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, discusses the impact of diabetes on Alzheimer disease-related dementia mortality among African Americans, including the burden and pathophysiology of Alzheimer disease and health care disparities in diagnosis among people with the disease.

Diabetes Modifies the Effect of Alzheimer Disease-Related Dementia Mortality Among African Americans

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

A biweekly podcast for early career researchers, bringing together fantastic guests to discuss their research, careers + much more. 

Dedicated to sharing the science, encouraging collaborations, attracting more people to the field, and supporting those already here to succeed.

Brought to you by https://www.dementiaresearcher.nihr.ac.uk at University College London, in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia - everything you need, all in one place. supporting early career researchers across the world

Register today to recieve weekly bulletins, with news, funding opportunities, jobs, and events.

New tracks tagged #Alzheimer Disease